XML 66 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
Net Income (Loss) per Common Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Numerator [Abstract]        
Net income (loss) attributable to Roivant Sciences Ltd. $ 5,096,184 $ (352,014) $ 4,500,041 $ (975,413)
Denominator [Abstract]        
Weighted average shares outstanding, basic (in shares) 800,587,716 713,319,399 776,759,728 703,054,773
Effect of dilutive common stock equivalents (in shares) 43,873,969 0 47,550,285 0
Weighted average shares outstanding, diluted (in shares) 844,461,685 713,319,399 824,310,013 703,054,773
Net income (loss) per common share, basic (in dollars per share) $ 6.37 $ (0.49) $ 5.79 $ (1.39)
Net income (loss) per common share, diluted (in dollars per share) $ 6.03 $ (0.49) $ 5.46 $ (1.39)
Stock Options and Performance Stock Options [Member]        
Denominator [Abstract]        
Potentially dilutive common stock were excluded from computation of diluted net income (loss) per common share (in shares)     65,518,394 154,631,025
Restricted Stock Units and Performance Stock Units (Non-vested) [Member]        
Denominator [Abstract]        
Potentially dilutive common stock were excluded from computation of diluted net income (loss) per common share (in shares)     5,422,465 22,153,774
March 2020 CVARs [Member]        
Denominator [Abstract]        
Potentially dilutive common stock were excluded from computation of diluted net income (loss) per common share (in shares) [1]     17,548,368 32,011,996
November 2021 CVARs (Non-vested) [Member]        
Denominator [Abstract]        
Potentially dilutive common stock were excluded from computation of diluted net income (loss) per common share (in shares)     359,730 3,609,021
Restricted Common Stock (Non-vested) [Member]        
Denominator [Abstract]        
Potentially dilutive common stock were excluded from computation of diluted net income (loss) per common share (in shares)     238,059 730,522
Earn-Out Shares (Non-vested) [Member]        
Denominator [Abstract]        
Potentially dilutive common stock were excluded from computation of diluted net income (loss) per common share (in shares)     3,080,387 3,080,387
Private Placement Warrants [Member]        
Denominator [Abstract]        
Potentially dilutive common stock were excluded from computation of diluted net income (loss) per common share (in shares)     0 10,214,365
Public Warrants [Member]        
Denominator [Abstract]        
Potentially dilutive common stock were excluded from computation of diluted net income (loss) per common share (in shares)     0 20,475,875
Other Stock Based Awards and Instruments Issued [Member]        
Denominator [Abstract]        
Potentially dilutive common stock were excluded from computation of diluted net income (loss) per common share (in shares)     4,147,404 6,178,990
[1] Refer to Note 9, “Share-Based Compensation” for details regarding settlement of CVARs.